Quinazoline based EGFR inhibitors containing a zinc binding moiety
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to quinazoline containing zinc-binding moiety based derivatives of Formula (IV) below.
These compounds have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and are useful in the treatment of EGFR-TK related diseases and disorders such as cancer. These compounds may further act as HDAC inhibitors.
-
Citations
12 Claims
- 1. A compound represented by the formula (IV):
- 5. A compound represented by formula (IV):
Specification